Replies to post #166913 on Avid Bioservices Inc (CDMO)

[sulaco]

I was initially referring to the SITC poster


which did not mention survival. (The results of which, by the way, you conveniently ignore.)

A mistake was made adding the Keystone study to that group. It does mention superior tumor suppression with anti-CTLA-4 and Bavi as well as a longer survival time (again, ALL conveniently ignored by you.)

Take your subset analysis on Figure 2 and run with it. KOL's disagree with you.

Yup.